US · Technology · Scientific & Technical Instruments
EPS came in at -0.45 against a street estimate of -0.75 — a beat of 40.0%.
with an average price target of $2.00.
CONFIDENT MicroVision reported accelerating commercial traction, sharply higher revenue and lower cash burn, while targeting 2027 revenue of approximately $20 million and continued funding discipline. Q3 FY26 Management cited IRIS orders across industrial, security and defense applications in North America and Europe, plus expanding ITS activity. The analyst focused on MicroVision Semiconductor, commercial acceleration, margins and the workforce reduction. Management emphasized internal technology support, broader customer demand and disciplined cost alignment, without promising a one-for-one OpEx reduction. 2026-10-28…
Full summary in the app.
| Fund | Stake |
|---|---|
| Vanguard Capital Management, LLC | 4.20% |
| Vanguard Portfolio Management, LLC | 1.78% |
| BlackRock Inc | 1.26% |
| Geode Capital Management, LLC | 1.12% |
| Millennium Management LLC | 0.75% |
| Vanguard Fiduciary Trust Co | 0.58% |
| Morgan Stanley - Brokerage Accounts | 0.54% |
| UBS Group AG | 0.52% |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Microvision Inc — free to start.
Open in the appGoogle PlayApp StoreData updated 2026-11-07.